Many payers are turning to creative strategies to improve members' medication use amid intense pressure to rein in costs and improve outcomes.
Pharmacy
In a recent survey, Premier Inc. found that a majority of member health systems report that shortages are affecting patient care, often leading to increased costs as well as cancelled or delayed surgical procedures.
Jewel-Osco pharmacies now sell the opioid overdose antidote Narcan — known generically as naloxone — without a prescription, according to a report from the Chicago Tribune.
Walmart unveiled a pharmacy initiative Jan. 17 to supply customers with a product to facilitate the safe disposal of excess opioids.
In a recent press release from Abbott, they announced FreeStyle® Libre System, the company's revolutionary new continuous glucose monitoring (CGM) system, is now available to Medicare patients, having met the codes for therapeutic CGM systems used for coverage by the U.S.…
Advertisement
As the number of fentanyl-related overdoses continue to rise, more emergency medical workers and law enforcement officers run the risk of overdosing due to secondhand exposure to the potent substance.
The Institute for Genomic Medicine at the Columbus, Ohio-based Nationwide Children's Hospital sequences hundreds of human genomes each year in the hopes of tailoring children's cancer care to their individual mutations, reports The Columbus Dispatch.
CMS lifted sanctions on Bloomfield, Conn.-based Cigna restricting the payer from marketing and enrolling members in its Medicare Advantage prescription drug and Medicare Part D plans, according to a June 16 Securities and Exchange Commission filing.
Snehal Doshi. Vice President of Pharmacy Services at WellStar Health System (Marietta, Ga.). During Mr. Doshi’s tenure, WellStar Health System received the Georgia Hospitals Association’s Quality and Patient Safety Award. Before joining WellStar, Mr. Doshi was president of prescribed minimum benefits…
Bloomfield, Conn.-based Cigna dropped coverage for Mylan's EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative according to the payer's prescription drug list changes, which were effective Jan. 7.